We evaluated the association of HIF1A-AS2 with clinicopathological factors in two independent cohorts: the FUSCC cohort (cDNA from 106 CRC samples and paired normal samples) and; the TMA cohort (paraffin sections of 272 CRC samples). The gene discussed is HIF1A; the disease is colorectal carcinoma.